Developer docs
API playgroundTry for free, no card

Search company profiles

BrainCheck

Full company profile

uuid00008k5

Namestring
BrainCheck
Legal namestring
BrainCheck, Inc.
Websiteurl
braincheck.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

BrainCheck is a digital cognitive assessment and care planning platform that enables clinicians to detect, monitor, and manage cognitive impairment across clinical and research settings. Founded in 2015 and headquartered in Austin, Texas, the company offers a cloud-first SaaS platform centered on BrainCheck Assess, an FDA Class II-cleared 15-minute digital cognitive assessment covering five domains, with a reported 0.77 correlation to the MoCA benchmark. The platform extends beyond assessment to include BrainCheck Plan for care planning, BrainCheck Screen for rapid screening, and more than 30 validated clinical evaluation tools, supported by deep workflow integrations with Epic and athenahealth EHRs.

The company monetizes through subscription SaaS agreements with order-form pricing, supplemented by professional services for EHR integration, training, and custom development, while offering a self-serve sign-up tier for small primary care practices serving fewer than 1,000 patients aged 65 and older. Customers span large health systems and value-based care organizations (Cleveland Clinic, UPMC, Mount Sinai, Stanford, MD Anderson, Bon Secours), primary care providers, neurology and psychiatry specialists, and 46 academic research institutions, with 640,000+ cumulative assessments and 14,000+ care plans completed across 500+ healthcare organizations. Distribution combines a sales-led enterprise motion targeting health systems and ACOs with a PLG self-serve channel and is backed by approximately $49.68 million in cumulative funding, including a $13 million Series A in February 2026 led by Next Coast Ventures.

Short descriptiontext

BrainCheck is a digital cognitive assessment and care planning platform serving health systems, primary care providers, and research institutions with its FDA Class II-cleared BrainCheck Assess tool and integrated care workflow software.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersAustin, United States
HQ citystring
Austin
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital cognitive assessment, cognitive care platform, clinical decision support, neurological screening tools, brain health software
Industry1 code
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Digital Health Cognitive Assessment Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Subscription-based access to the BrainCheck Platform for conducting cognitive assessments, care planning and related services. Fees are set forth in Order forms with subscription terms and payment terms.

braincheck.com
2Additional Services
TypeProfessional Services
Description

Additional services including technical support, training, custom development, and EHR integration assistance, billed per Order form agreements.

braincheck.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Self-serve for small practices
ModelSubscriptionBilling cadenceAnnual
Notes

Self-sign-up option for practices with fewer than 1,000 patients who are 65+; no sales calls or onboarding delays required.

braincheck.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1BrainCheck Assess
Description

FDA Class II digital cognitive assessment tool - 15 minutes, 5 domains, detects subtle signs of cognitive impairment associated with dementias including Alzheimer's disease. The platform's flagship product and only FDA-registered Class II component.

braincheck.com
Core offering1 text field

BrainCheck provides a cloud-based digital cognitive assessment and care planning platform built around BrainCheck Assess, an FDA Class II digital cognitive assessment medical device. The platform supports the full cognitive care workflow — screening, assessment, interpretation, care planning, and longitudinal follow-up — and integrates with Epic and athenahealth EHRs. It is sold to health systems, primary care providers, neurologists, psychiatrists, and research institutions for both in-clinic and remote cognitive evaluations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • BrainCheck Assess scores correlate with MoCA (correlation coefficient 0.77)
+4 more records
Product overview1 text field

BrainCheck offers a unified digital cognitive assessment and care planning platform centered around BrainCheck Assess™ — its FDA Class II digital cognitive assessment (the only regulated component) — combined with BrainCheck Plan for longitudinal care planning, BrainCheck Screen for rapid screenings, and 30+ validated clinical evaluation tools including screeners and assessments. The platform enables cognitive care over time through screening, assessment, interpretation, care planning, and follow-up workflows. The company is also developing an eConsult platform to connect primary care providers with cognitive specialists. BrainCheck operates as a SaaS-based platform with EHR integration capabilities (Epic, athenahealth) and is used across clinical and research settings.

Product and service4 records
1BrainCheck Assess
2BrainCheck Plan
3BrainCheck Screen
4Clinical Evaluation Tools
Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeTechnology or Integration
Description

EHR integration partner enabling cognitive screening, assessment, and follow-up within Epic workflows. First EHR integration led by Molly Penna, VP of Customer Success.

Strategic tierCoreTypeTechnology or Integration
Description

EHR integration partner. Nathan Bell, CMO of Frontier Psychiatry, noted deep integration into Athena system enables simple scale and sustainability.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner and one of 46 research hospitals using BrainCheck. Active in clinical validation and cognitive assessment research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partner and one of 46 research hospitals nationwide using BrainCheck for cognitive assessment research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Conducted peer-reviewed longitudinal study tracking 630 COVID-19 hospitalized patients over 36 months using BrainCheck, identifying four distinct cognitive trajectories.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partner and customer among 46 research hospitals using BrainCheck for cognitive health management.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partner and customer using BrainCheck for cognitive assessment in cancer patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partner recipient of JH AITC grant funding for AI projects including BrainCheck digital cognitive assessments.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner collaborating with BrainCheck on cognitive health research initiatives.

10PREDICTOM Consortium
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Pan-European Alzheimer's early detection initiative (4,000 adults across 7 countries) where BrainCheck Assess serves as the cognitive assessment tool. Study runs November 2023 through October 2027.

braincheck.com
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic research partner in BrainCheck's ongoing clinical research and academic partnerships.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

International academic research partner in BrainCheck's collaborative research network.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

International research partner in BrainCheck's academic partnership network.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Publicly listed digital cognitive assessment company (ASX: CGS) offering computerized tests for clinical trials, healthcare, and research — directly competing with BrainCheck Assess in both clinical and research settings, with deeper penetration in pharmaceutical trials.

TypeDirect peer
Description

UK-based provider of CANTAB digital cognitive assessment tools used in clinical trials, healthcare, and research. A direct competitor in computerized cognitive testing, with strong international footprint and pharma/CRO customer base.

TypeDirect peer
Description

Digital cognitive health platform focused on early detection of cognitive impairment and dementia, including primary care deployment. Competes directly with BrainCheck in primary care cognitive assessment and longitudinal brain health management.

TypeDirect peer
Description

Digital cognitive assessment and brain health company offering screening tools for cognitive decline and Alzheimer's risk. Direct competitor in digital cognitive testing for health systems, payers, and consumer health.

TypeEmerging player
Description

AI-driven digital cognitive assessment platform using augmented reality and smartphone-based tasks to detect early signs of cognitive impairment. Competes with BrainCheck in the digital neurocognitive assessment space, particularly in pharma/clinical trials.

TypeEmerging player
Description

Speech-based digital biomarker platform for cognitive impairment assessment, focused on clinical trials and healthcare applications. Adjacent competitor with narrower modality but overlapping customer base in pharma and clinical research.

TypeBroad incumbent
Description

Large clinical trial technology provider offering electronic clinical outcome assessments (eCOA) including cognitive batteries. Overlaps with BrainCheck in research and clinical trial cognitive assessment, but serves a broader eCOA portfolio.

TypeBroad incumbent
Description

Major clinical trial endpoint technology company with imaging, eCOA, and digital cognitive assessment capabilities. Competes with BrainCheck in cognitive assessment delivery for pharmaceutical trials, with a much larger scale and broader offering.

TypeEmerging player
Description

Provider of tau PET imaging agents and biomarkers for Alzheimer's disease research and diagnostics. Adjacent competitor in the broader Alzheimer's/dementia diagnostic pathway, particularly relevant to BrainCheck's positioning in early detection.

TypeOthers
Description

Virtual care and care navigation platform serving employers, health systems, and consumers. Not a direct cognitive assessment peer, but competes for value-based care and employer-sponsored virtual care budgets where BrainCheck also sells.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers14 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds13 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors15 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BrainCheck

Digital Health Cognitive Assessment Softwarebraincheck.com

BrainCheck is a digital cognitive assessment and care planning platform serving health systems, primary care providers, and research institutions with its FDA Class II-cleared BrainCheck Assess tool and integrated care workflow software.

What BrainCheck does

BrainCheck is a digital cognitive assessment and care planning platform that enables clinicians to detect, monitor, and manage cognitive impairment across clinical and research settings. Founded in 2015 and headquartered in Austin, Texas, the company offers a cloud-first SaaS platform centered on BrainCheck Assess, an FDA Class II-cleared 15-minute digital cognitive assessment covering five domains, with a reported 0.77 correlation to the MoCA benchmark. The platform extends beyond assessment to include BrainCheck Plan for care planning, BrainCheck Screen for rapid screening, and more than 30 validated clinical evaluation tools, supported by deep workflow integrations with Epic and athenahealth EHRs.

The company monetizes through subscription SaaS agreements with order-form pricing, supplemented by professional services for EHR integration, training, and custom development, while offering a self-serve sign-up tier for small primary care practices serving fewer than 1,000 patients aged 65 and older. Customers span large health systems and value-based care organizations (Cleveland Clinic, UPMC, Mount Sinai, Stanford, MD Anderson, Bon Secours), primary care providers, neurology and psychiatry specialists, and 46 academic research institutions, with 640,000+ cumulative assessments and 14,000+ care plans completed across 500+ healthcare organizations. Distribution combines a sales-led enterprise motion targeting health systems and ACOs with a PLG self-serve channel and is backed by approximately $49.68 million in cumulative funding, including a $13 million Series A in February 2026 led by Next Coast Ventures.

BrainCheck firmographics

Firmographics
Name
BrainCheck
Legal name
BrainCheck, Inc.
Website
https://braincheck.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
51–100 employees
Short description
BrainCheck is a digital cognitive assessment and care planning platform serving health systems, primary care providers, and research institutions with its FDA Class II-cleared BrainCheck Assess tool and integrated care workflow software.
Ownership category
akta.pro rank

BrainCheck industry classification

Industry
Product category
Digital Health Cognitive Assessment Software
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Digital cognitive assessment
  • Cognitive care platform
  • Clinical decision support
  • Neurological screening tools
  • Brain health software

Where BrainCheck is headquartered

Location

Headquarters

HQ city
Austin
HQ country
United States
HQ region
North America

Offices3 records

Markets served

BrainCheck business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Platform Subscription: Subscription-based access to the BrainCheck Platform for conducting cognitive assessments, care planning and related services. Fees are set forth in Order forms with subscription terms and payment terms.
  2. Additional Services: Additional services including technical support, training, custom development, and EHR integration assistance, billed per Order form agreements.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualSelf-serve for small practices

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

BrainCheck product offering

Product offering

Core offering

BrainCheck provides a cloud-based digital cognitive assessment and care planning platform built around BrainCheck Assess, an FDA Class II digital cognitive assessment medical device. The platform supports the full cognitive care workflow — screening, assessment, interpretation, care planning, and longitudinal follow-up — and integrates with Epic and athenahealth EHRs. It is sold to health systems, primary care providers, neurologists, psychiatrists, and research institutions for both in-clinic and remote cognitive evaluations.

Product overview

BrainCheck offers a unified digital cognitive assessment and care planning platform centered around BrainCheck Assess™ — its FDA Class II digital cognitive assessment (the only regulated component) — combined with BrainCheck Plan for longitudinal care planning, BrainCheck Screen for rapid screenings, and 30+ validated clinical evaluation tools including screeners and assessments. The platform enables cognitive care over time through screening, assessment, interpretation, care planning, and follow-up workflows. The company is also developing an eConsult platform to connect primary care providers with cognitive specialists. BrainCheck operates as a SaaS-based platform with EHR integration capabilities (Epic, athenahealth) and is used across clinical and research settings.

Differentiator

Problem solved

Functional benefit

Brands

  • BrainCheck Assess: FDA Class II digital cognitive assessment tool - 15 minutes, 5 domains, detects subtle signs of cognitive impairment associated with dementias including Alzheimer's disease. The platform's flagship product and only FDA-registered Class II component.

Products and services

  • BrainCheck Assess
  • BrainCheck Plan
  • BrainCheck Screen
  • Clinical Evaluation Tools

Quantifiable outcome

  • BrainCheck Assess scores correlate with MoCA (correlation coefficient 0.77)
  • +4 more outcomes

Companies that use BrainCheck

Customer profile

Named customers14 records

Segments4 records

Ideal customer profiles4 records

BrainCheck technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability5 records

Feature5 records

BrainCheck partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and minor.

  • EpiccoreTechnology or IntegrationEHR integration partner enabling cognitive screening, assessment, and follow-up within Epic workflows. First EHR integration led by Molly Penna, VP of Customer Success.
  • athenahealthcoreTechnology or IntegrationEHR integration partner. Nathan Bell, CMO of Frontier Psychiatry, noted deep integration into Athena system enables simple scale and sustainability.
  • University of Texas at AustincoreStrategic or Co-development PartnerAcademic research partner and one of 46 research hospitals using BrainCheck. Active in clinical validation and cognitive assessment research.
  • Stanford UniversitycoreStrategic or Co-development PartnerResearch partner and one of 46 research hospitals nationwide using BrainCheck for cognitive assessment research.
  • UTHealth HoustoncoreStrategic or Co-development PartnerConducted peer-reviewed longitudinal study tracking 630 COVID-19 hospitalized patients over 36 months using BrainCheck, identifying four distinct cognitive trajectories.
  • Mount SinaicoreStrategic or Co-development PartnerResearch partner and customer among 46 research hospitals using BrainCheck for cognitive health management.
  • MD Anderson Cancer CentercoreStrategic or Co-development PartnerResearch partner and customer using BrainCheck for cognitive assessment in cancer patients.
  • Johns Hopkins UniversitycoreStrategic or Co-development PartnerResearch partner recipient of JH AITC grant funding for AI projects including BrainCheck digital cognitive assessments.
  • Baylor College of MedicinecoreStrategic or Co-development PartnerAcademic research partner collaborating with BrainCheck on cognitive health research initiatives.
  • PREDICTOM ConsortiumcoreStrategic or Co-development PartnerPan-European Alzheimer's early detection initiative (4,000 adults across 7 countries) where BrainCheck Assess serves as the cognitive assessment tool. Study runs November 2023 through October 2027.
  • University of MichiganminorStrategic or Co-development PartnerAcademic research partner in BrainCheck's ongoing clinical research and academic partnerships.
  • University of MelbourneminorStrategic or Co-development PartnerInternational academic research partner in BrainCheck's collaborative research network.
  • CHU Sainte-Justine Research CenterminorStrategic or Co-development PartnerInternational research partner in BrainCheck's academic partnership network.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

BrainCheck competitors and assessment

Company assessment

Direct peers

  • Cogstate: Publicly listed digital cognitive assessment company (ASX: CGS) offering computerized tests for clinical trials, healthcare, and research — directly competing with BrainCheck Assess in both clinical and research settings, with deeper penetration in pharmaceutical trials.
  • Cambridge Cognition: UK-based provider of CANTAB digital cognitive assessment tools used in clinical trials, healthcare, and research. A direct competitor in computerized cognitive testing, with strong international footprint and pharma/CRO customer base.
  • Linus Health: Digital cognitive health platform focused on early detection of cognitive impairment and dementia, including primary care deployment. Competes directly with BrainCheck in primary care cognitive assessment and longitudinal brain health management.
  • Neurotrack Technologies: Digital cognitive assessment and brain health company offering screening tools for cognitive decline and Alzheimer's risk. Direct competitor in digital cognitive testing for health systems, payers, and consumer health.

Emerging players

  • Altoida: AI-driven digital cognitive assessment platform using augmented reality and smartphone-based tasks to detect early signs of cognitive impairment. Competes with BrainCheck in the digital neurocognitive assessment space, particularly in pharma/clinical trials.
  • Winterlight Labs: Speech-based digital biomarker platform for cognitive impairment assessment, focused on clinical trials and healthcare applications. Adjacent competitor with narrower modality but overlapping customer base in pharma and clinical research.
  • Cerveau Technologies: Provider of tau PET imaging agents and biomarkers for Alzheimer's disease research and diagnostics. Adjacent competitor in the broader Alzheimer's/dementia diagnostic pathway, particularly relevant to BrainCheck's positioning in early detection.

Broad incumbents

  • Signant Health (formerly MedAvante-Prophase): Large clinical trial technology provider offering electronic clinical outcome assessments (eCOA) including cognitive batteries. Overlaps with BrainCheck in research and clinical trial cognitive assessment, but serves a broader eCOA portfolio.
  • Clario (formerly Bioclinica/ERT): Major clinical trial endpoint technology company with imaging, eCOA, and digital cognitive assessment capabilities. Competes with BrainCheck in cognitive assessment delivery for pharmaceutical trials, with a much larger scale and broader offering.

Others

  • Included Health: Virtual care and care navigation platform serving employers, health systems, and consumers. Not a direct cognitive assessment peer, but competes for value-based care and employer-sponsored virtual care budgets where BrainCheck also sells.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

BrainCheck social profiles

Digital presence

BrainCheck compliance and trust

Trust signal

Compliance2 records

BrainCheck financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BrainCheck leadership team

Management profile

Number of profiles

Profiles13 records

BrainCheck funding detail

Funding detail

Funding overview

Funding rounds13 records

Investors15 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BrainCheck M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BrainCheck

What does BrainCheck do?

BrainCheck provides a cloud-based digital cognitive assessment and care planning platform built around BrainCheck Assess, an FDA Class II digital cognitive assessment medical device. The platform supports the full cognitive care workflow — screening, assessment, interpretation, care planning, and longitudinal follow-up — and integrates with Epic and athenahealth EHRs. It is sold to health systems, primary care providers, neurologists, psychiatrists, and research institutions for both in-clinic and remote cognitive evaluations.

Is BrainCheck a public or private company?

BrainCheck is a private company. It is classified as venture growth investor backed and is currently operating.

When was BrainCheck founded?

BrainCheck was founded in 2015. It employs 51 to 100 people.

Where is BrainCheck based?

BrainCheck is headquartered in Austin, United States, in the North America region.

How does BrainCheck make money?

Two revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are additional Services.

Who are BrainCheck's main competitors?

Direct peers on record are Cogstate, Cambridge Cognition, Linus Health and Neurotrack Technologies. Emerging players are Altoida, Winterlight Labs and Cerveau Technologies. Broad incumbents are Signant Health (formerly MedAvante-Prophase) and Clario (formerly Bioclinica/ERT). Included Health is listed as an others.

Does BrainCheck have an API?

No public API is recorded for BrainCheck.

What industry is BrainCheck in?

BrainCheck's product category is Digital Health Cognitive Assessment Software. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital). Its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Neurology liveBrainCheck Assess Cognitive Test Demonstrates Strong Alignment With Traditional Montreal Cognitive AssessmentA study of 55 older adults found BrainCheck Assess scores correlated 0.77 with MoCA cutoffs, with MoCA cutoffs of 26 and 19 corresponding to BrainCheck scores of 89.6 and 68.5. The results align with recommended BrainCheck cutoffs of 85 and 70, confirming its accuracy as a digital cognitive assessment tool.FinancialContent Business PageBrainCheck® Launches Population Analytics to Scale Proactive Cognitive CareBrainCheck launched Population Analytics, a new solution that analyzes up to 40 factors within structured electronic health record data to help health systems identify and prioritize patients for cognitive care evaluation.Joplin GlobeAP Business SummaryBrief at 8:19 a.m. EDT | National Business | joplinglobe.comA Texas-based company, BrainCheck, announced the launch of its population analytics tool aimed at scaling proactive cognitive care. This development is part of its strategy to improve cognitive health management.FinancialContent Business PageArticles from BrainCheckBrainCheck, a cognitive assessment and care management platform for physicians, announced the appointment of Trey Swain as Chief Financial Officer and Matthew Cerullo as Chief Revenue Officer to its executive leadership team. The executive appointments follow BrainCheck's $10 million Series B funding round completed in November 2021. The announcement underscores the company's focus on strengthening its executive management as part of its long-term strategic growth plans.AijournNew Peer-Reviewed Study Using BrainCheck Identifies Four Distinct Cognitive Trajectories in Patients Hospitalized for COVID-19UTHealth Houston researchers published a peer-reviewed longitudinal study using BrainCheck's cognitive assessment platform that tracked 630 COVID-19 hospitalized patients over 36 months, identifying four distinct cognitive trajectories. The study found that 48% of patients maintained normal cognition throughout the period while 32% showed persistent impairment, 14% recovered over time, and 7% exhibited delayed cognitive decline emerging only at later time points. BrainCheck is highlighting this research as evidence that ongoing longitudinal monitoring may be necessary for post-COVID cognitive care, as single assessments may miss patients who decline at later stages.Business Wire BlogNew Peer-Reviewed Study Using BrainCheck Identifies Four Distinct Cognitive Trajectories in Patients Hospitalized for COVID-19Researchers at UTHealth Houston published a peer-reviewed longitudinal study in The Journal of Neuropsychiatry and Clinical Neurosciences that used BrainCheck's digital cognitive assessment platform to track 630 patients hospitalized for severe COVID-19 over a 36-month period. The study identified four distinct cognitive trajectories: 48% maintained normal function throughout, 32% showed persistent impairment, 14% recovered from impaired to unimpaired, and 7% experienced delayed cognitive decline that emerged only at later time points. The findings highlight the clinical value of ongoing longitudinal cognitive monitoring in post-COVID care and demonstrate BrainCheck's capability for multi-year, remote patient assessment.Towards HealthcareCognitive Assessment and Training in Healthcare Market Uplifts at 27.06% CAGR by 2034Market research predicts the global cognitive assessment and training in healthcare industry will grow from USD 6.66 billion in 2024 to USD 73.08 billion by 2034, at a CAGR of 27.06%, driven by rising prevalence of neurological disorders and technological advancements. North America dominated the market in 2024, while Asia-Pacific is projected to be the fastest-growing region over the forecast period. Recent industry activity includes Ivory's $1 million funding round, Medidata's collaboration with Cogstate, UPMC Enterprises' $15 million investment in BrainCheck, and Virtuleap's launch of Cogniclear VR cognitive assessment tool.GoogleBrainCheck Secures $13M to Scale Its AI-Powered Cognitive Care PlatformBrainCheck raised $13 million in Series A funding led by Next Coast Ventures to scale its AI-powered cognitive assessment platform. The company plans to expand EHR integration and longitudinal monitoring, with over 500 healthcare organizations and 640,000 assessments completed. The capital will support population-scale deployment and AI-assisted features.Pulse 2.0BrainCheck: $13 Million Series A Raised To Scale AI-Enabled Cognitive Care PlatformBrainCheck raised $13 million in Series A financing led by Next Coast Ventures, with participation from S3 Ventures and UPMC Enterprises. The Austin- and New York-based company develops a digital cognitive assessment platform, currently used by over 500 healthcare organizations with 640,000 assessments completed. The funding will support workflow integration, longitudinal monitoring, and AI-assisted infrastructure for value-based care.Texas CEO MagazineTexas Weekly Deal HighlightsTexas venture capital deal activity for the week of March 1, 2026 featured deals across healthcare, defense tech, and blank check companies in Austin and Houston. BrainCheck, a digital cognitive assessment and care management solutions provider, raised $13 million in a Series A round led by Next Coast Ventures with participation from UMP Cares and S3 Ventures, bringing its total raised to date to $49.68 million.